Market Tracker

03/06 12:45pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

12.23
BATS BZX Real-Time Price
As of 12:29pm ET
 -0.25 / -2.00%
Today’s Change
4.13
Today|||52-Week Range
12.50
+8.23%
Year-to-Date

Today’s Trading

Previous close12.48
Today’s open12.21
Day’s range12.15 - 12.48
Volume681,762
Average volume (3 months)1,699,857
Market cap$1.3B
Dividend yield--
Data as of 12:17pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-27.29%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+1.10+1.60%
NLNKNewLink Genetics Cor...-0.19-0.40%
ACHNAchillion Pharmaceut...+0.15+1.36%
USNAUSANA Health Science...-0.20-0.20%
Data as of 12:31pm ET, 03/06/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts